4//SEC Filing
Bigora Sian 4
Accession 0001567619-23-000320
CIK 0001533743other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:38 PM ET
Size
10.3 KB
Accession
0001567619-23-000320
Insider Transaction Report
Form 4
Bigora Sian
Chief Development Officer
Transactions
- Award
Restricted Stock Units
2023-01-01+75,907→ 431,985 totalExercise: $0.00→ Common Stock (75,907 underlying) - Award
Restricted Stock Units
2022-12-31+13,851→ 356,073 totalExercise: $0.00→ Common Stock (13,851 underlying) - Award
Restricted Stock Units
2023-01-01+48,490→ 480,475 totalExercise: $0.00→ Common Stock (48,490 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
- [F2]Each restricted stock units represents a contingent right to receive one share of stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.
- [F3]Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001799365
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:38 PM ET
- Size
- 10.3 KB